Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Assets (2017 - 2025)

Neuronetics (STIM) has disclosed Assets for 9 consecutive years, with $141.6 million as the latest value for Q4 2025.

  • Quarterly Assets changed 0.46% to $141.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $141.6 million through Dec 2025, changed 0.46% year-over-year, with the annual reading at $141.6 million for FY2025, 0.46% changed from the prior year.
  • Assets for Q4 2025 was $141.6 million at Neuronetics, down from $145.5 million in the prior quarter.
  • The five-year high for Assets was $152.3 million in Q1 2021, with the low at $74.1 million in Q3 2024.
  • Average Assets over 5 years is $123.3 million, with a median of $126.4 million recorded in 2022.
  • The sharpest move saw Assets fell 22.01% in 2023, then surged 96.26% in 2025.
  • Over 5 years, Assets stood at $141.2 million in 2021, then decreased by 17.23% to $116.9 million in 2022, then dropped by 0.9% to $115.8 million in 2023, then grew by 21.65% to $140.9 million in 2024, then increased by 0.46% to $141.6 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $141.6 million, $145.5 million, and $134.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.